Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Akerman Senterfitt
Akerman Senterfitt and WolfBlock Discussions Terminated
September 21st, 2008
Akerman Senterfitt announced that its Board of Directors has decided against a potential combination with WolfBlock LLP, a Philadelphia-based law firm. Andrew M. Smulian, chairman of Akerman, explained, "Certain client conflict issues became an impediment to moving forward and were not resolved. Under the circumstances, we determined that it is not in our best interests to pursue the transaction. We appreciate the cooperative spirit of our friends at WolfBlock, and we wish them well." Akerman Senterfitt has over 500 attorneys and government affairs professionals and has been expanding its footprint at an active pace, beyond its broad network in Florida, where it has a...
Source: Pharma Investments, Ventures & Law Weekly (2008-09-21)
|
